ACTIVE

PHARMANAUS

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-10,9 k €

-56.5% YoY

Gross margin

-2,7 k €

-186.9% YoY

Equity

633,2 k €

-1.7% YoY

What does PHARMANAUS do?

PHARMANAUS is a Private limited company incorporated in 2001. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Herve.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0475.087.489

Incorporation

27/06/2001

Legal form

Private limited company

Registered office

Rue des deux Tilleuls 44
4652 Herve · WallonieSee on map

Contributed capital

388 600,00 €

Latest accounts

31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 47740Retail sale of medical and orthopaedic goods in specialised stores 47741Retail sale of medical and orthopaedic goods in specialised stores 47750Retail sale of cosmetic and toilet articles in specialised stores+3

Joint committees (1)

Signals

Solid equityLow riskGood liquidity

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	-2,7 k €	-187%	3,1 k €	-87.4%	24,9 k €	+33.6%	18,6 k €	-91.1%	210,3 k €	+140%	87,7 k €	+2.2%	85,8 k €	-13.4%	99,1 k €	-10.0%	110,1 k €	-20.3%	138,2 k €	-0.7%	139,2 k €	+23.7%	112,5 k €	+26.0%	89,3 k €	-2.2%	91,3 k €	-0.5%	91,8 k €	+93.5%	47,4 k €	+152%	18,8 k €	-37.7%	30,1 k €	+1.9%	29,6 k €	+32.1%	22,4 k €
EBITDA	-3,5 k €	-253%	2,3 k €	-90.4%	23,6 k €	+87.4%	12,6 k €	-93.9%	207,6 k €	+144%	85 k €	+2.1%	83,2 k €	-13.8%	96,5 k €	-10.4%	107,7 k €	-20.5%	135,4 k €	-0.9%	136,6 k €	+24.4%	109,8 k €	+27.1%	86,4 k €	-2.7%	88,8 k €	-0.2%	89 k €	+304%	22 k €	+49.1%	14,8 k €	-38.5%	24 k €	-1.5%	24,4 k €	+37.6%	17,7 k €
Operating result	-13,5 k €	-45.0%	-9,3 k €	-155%	16,8 k €	+52.2%	11 k €	-94.7%	207,6 k €	+219%	65,1 k €	+3.2%	63,1 k €	-17.4%	76,3 k €	-12.7%	87,5 k €	-24.1%	115,2 k €	+0.0%	115,2 k €	+30.2%	88,5 k €	+36.1%	65 k €	-2.0%	66,4 k €	-0.2%	66,5 k €	+237%	19,7 k €	+478%	-5,2 k €	-230%	4 k €	+494%	-1 k €	+86.9%	-7,8 k €
Net result	-10,9 k €	-56.5%	-7 k €	-364%	2,6 k €	+584%	385,2 €	-99.7%	128,4 k €	+345%	28,9 k €	+15.2%	25,1 k €	-24.2%	33,1 k €	-6.2%	35,3 k €	-36.7%	55,7 k €	-17.8%	67,8 k €	+59.0%	42,6 k €	+109%	20,5 k €	-21.8%	26,2 k €	-6.2%	27,9 k €	+191%	9,6 k €	+161%	-15,7 k €	-116%	-7,3 k €	+39.3%	-12 k €	+38.0%	-19,4 k €
Balance sheet
Equity	633,2 k €	-1.7%	644,1 k €	-1.1%	651,1 k €	+0.3%	649,3 k €	-12.8%	744,9 k €	+20.7%	617,3 k €	+1.3%	609,2 k €	+4.3%	584,2 k €	+6.0%	551,1 k €	+6.8%	515,8 k €	+12.1%	460,2 k €	+11.6%	412,4 k €	+5.8%	389,7 k €	+5.5%	369,3 k €	+7.6%	343,1 k €	+8.8%	315,2 k €	+590%	-64,3 k €	-32.3%	-48,6 k €	-17.6%	-41,4 k €	-40.9%	-29,4 k €
Total assets	1,2 M €	-1.2%	1,2 M €	-1.2%	1,2 M €	-2.3%	1,2 M €	-10.6%	1,4 M €	+5.8%	1,3 M €	-2.8%	1,3 M €	-0.5%	1,4 M €	-1.7%	1,4 M €	-1.2%	1,4 M €	+1.5%	1,4 M €	-1.5%	1,4 M €	+0.0%	1,4 M €	-2.2%	1,4 M €	-3.9%	1,5 M €	-1.0%	1,5 M €	+819%	162,5 k €	-9.6%	179,8 k €	-10.5%	201 k €	-10.6%	224,7 k €
Cash	44,6 k €	-33.4%	67,1 k €	-23.1%	87,2 k €	-50.1%	174,7 k €	-86.1%	1,3 M €	+2238%	53,8 k €	-3.2%	55,6 k €	+72.8%	32,2 k €	+10.0%	29,2 k €	+10.6%	26,4 k €	-10.4%	29,5 k €	-28.8%	41,5 k €	+35.3%	30,6 k €	-13.9%	35,6 k €	-45.6%	65,4 k €	+112%	30,8 k €	+1949%	1,5 k €	-25.4%	2 k €	-13.8%	2,3 k €	-54.2%	5,1 k €
Debts	531,7 k €	-0.6%	535,1 k €	+1.8%	525,5 k €	-9.3%	579,1 k €	-6.4%	619 k €	-7.8%	671,2 k €	-6.1%	714,9 k €	-4.2%	746,3 k €	-6.8%	800,5 k €	-6.2%	853 k €	-4.8%	896 k €	-7.0%	963,8 k €	-2.2%	985,6 k €	-4.9%	1 M €	-7.3%	1,1 M €	-4.8%	1,2 M €	+418%	226,7 k €	-0.8%	228,5 k €	-5.2%	241 k €	-4.7%	252,8 k €
Other
Workforce	–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		0,4 ETP	+300%	0,1 ETP	-50.0%	0,2 ETP	0.0%	0,2 ETP	0.0%	0,2 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

Serge NAUS

Director

Active

Ended mandates

Serge NAUS

Manager · since 01 janvier 2010

Ended

Pierre-Emmanuel STASSEN

Manager · until 31 décembre 2009

Ended

PIERRE-MANUEL STASSEN

Manager

Ended

Serge NAUS

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	12/06/2026	28/03/2025	14/06/2024	28/04/2023	30/06/2022	15/04/2021
General meeting	27/05/2026	11/03/2025	31/05/2024	03/04/2023	20/06/2022	31/03/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	27/05/2026	12/06/2026	French	PDF
Micro model	31/12/2024	11/03/2025	28/03/2025	French	PDF
Micro model	31/12/2023	31/05/2024	14/06/2024	French	PDF
Abridged model	31/12/2022	03/04/2023	28/04/2023	French	PDF
Abridged model	31/12/2021	20/06/2022	30/06/2022	French	PDF
Abridged model	31/12/2020	31/03/2021	15/04/2021	French	PDF
Abridged model	31/12/2019	08/05/2020	10/08/2020	French	PDF
Abridged model	31/12/2018	03/04/2019	29/04/2019	French	PDF
Abridged model	31/12/2017	05/06/2018	03/07/2018	French	PDF
Abridged model	31/12/2016	06/06/2017	21/06/2017	French	PDF
Abridged model	31/12/2015	09/05/2016	08/07/2016	French	PDF
Abridged model	31/12/2014	30/06/2015	28/07/2015	French	PDF
Abridged model	31/12/2013	22/05/2014	05/06/2014	French	PDF
Abridged model	31/12/2012	30/06/2013	25/07/2013	French	PDF
Abridged model	31/12/2011	30/06/2012	16/07/2012	French	PDF
Abridged model	31/12/2010	15/06/2011	14/07/2011	French	PDF
Abridged model	31/12/2009	28/06/2010	19/07/2010	French	PDF
Abridged model	31/12/2008	17/06/2009	29/07/2009	French	PDF
Abridged model	31/12/2007	18/06/2008	16/07/2008	French	PDF
Abridged model	31/12/2006	20/06/2007	10/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

Serge NAUS

Director

Active

Ended mandates

Serge NAUS

Manager · since 01 janvier 2010

Ended

Pierre-Emmanuel STASSEN

Manager · until 31 décembre 2009

Ended

PIERRE-MANUEL STASSEN

Manager

Ended

Serge NAUS

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other04/01/2022
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
PDF
Registered office17/07/2014
SIEGE SOCIAL
PDF
Mandates03/02/2011
DEMISSIONS, NOMINATIONS
PDF
Mandates21/12/2010
DENOMINATION - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates09/03/2010
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates24/10/2003
DEMISSIONS, NOMINATIONS - DENOMINATION - SIEGE SOCIAL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-10,9 k €↓
2024
Annual accounts 2024-7 k €↓
2023
Annual accounts 20232,6 k €↑
2022
Annual accounts 2022385,2 €↓
2021
Annual accounts 2021128,4 k €↑
2020
Annual accounts 202028,9 k €↑
2019
Annual accounts 201925,1 k €↓
2018
Annual accounts 201833,1 k €↓
2017
Annual accounts 201735,3 k €↓
2016
Annual accounts 201655,7 k €↓
2015
Annual accounts 201567,8 k €↑
2014
Annual accounts 201442,6 k €↑
2013
Annual accounts 201320,5 k €↓
2012
Annual accounts 201226,2 k €↓
2011
Annual accounts 201127,9 k €↑
2010
Annual accounts 20109,6 k €↑
2009
Annual accounts 2009-15,7 k €↓
2008
Annual accounts 2008-7,3 k €↑
2007
Annual accounts 2007-12 k €↑
2006
Annual accounts 2006-19,4 k €
27/06/2001
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMANAUS

Overview

What does PHARMANAUS do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline